Abstract:Allergic asthma is a common airway inflammatory disease and mainly caused by abnormal immune responses to allergens and viruses. The precise mechanisms of airway inflammation and airway hyper-responsiveness (AHR) are still not completely understood. CD4+ helper T cells (Th cells) serve as critical regulators of allergic immunity. The imbalance between T helper 9 (Th9) cells and forkhead box protein 3 (Foxp3)+ regulatory T (Treg) cells may contribute to airway inflammation in asthma. Epimedin C, a dominant compound isolated from Herba Epimedii, has shown anti-inflammatory effects and the immunoregulatory activity, such as increase of lymphocyte proliferation. However, the protective role of epimedin C in an experimental model of ovalbumin (OVA)-induced allergic airway inflammation and the underlying mechanism remain unknown. Female BALB/c mice were sensitized by intraperitoneal injection (i.p.) of OVA plus aluminum hydroxide (Alum) and subsequently challenged with an aerosol of 3% OVA in saline. Mice were treated with different concentrations of epimedin C (20 mg/kg/d, 40 mg/kg/d, 80 mg/kg/d) for 4 weeks. Experimental endpoints were evaluated via the analysis of AHR to acetyl-β-methacholine (Mch), differential inflammatory cell counts, concentrations of cytokines interleukin-9 (IL-9), IL-4 and IL-10 in bronchoalveolar lavage fluid (BALF), serum OVA-specific IgE level, as well as airway inflammation, mucus secretion and collagen deposition in mice. Mechanistically, we investigated the percentages of Th9 cells and Treg cells, as well as mRNA levels of IL-9 and transcription factor Foxp3 in lungs. Furthermore, the proteins expression of nuclear factor-κB (NF-κB) family members p105/p50, RelA, p100/p52 and RelB, as well as mitogen-activated protein kinase (MAPK) family members extracellular signal-regulated kinase 1/2 (ERK1/2) and p38 MAPK was detected. Epimedin C dose-dependently attenuated AHR, airway inflammation, mucus hypersecretion and collagen deposition in OVA-induced murine asthma model. The expression levels of IL-9, IL-4 and OVA-specific IgE were significantly decreased while IL-10 was increased by epimedin C. We further confirmed that epimedin C decreased the percentage of lung Th9 cells with lower mRNA expression of IL-9 and increased the percentage of lung Treg cells with higher mRNA expression of Foxp3. In addition, epimedin C dose-dependently decreased the protein levels of p52, RelB, phosphorylation of ERK1/2 and p38 MAPK which are pivotal to the development of Th9 cells and Treg cells. Collectively, epimedin C could inhibit pathophysiological features of asthma by reconstruction of the balance between Th9 cells and Treg cells through regulation of the noncanonical NF-κB p52/RelB pathway and MAPKs activation. These findings suggest epimedin C as a potential remedy for inflammatory airway diseases.

[Influence of regulatory peptides on the secretion of interleukins from bronchial epithelial cells of the rabbit].

Involvement of Multiple Transcription Factors in Regulation of IL-β-induced MCP-1 Expression in Alveolar Type II Epithelial Cells.

Regulation Of Viral Infection-Induced Airway Remodeling Cytokine Production By The Tlr3-Egfr Signaling Pathway In Human Bronchial Epithelial Cells

Interleukin‐1β Induces Β‐calcitonin Gene‐related Peptide Secretion in Human Type II Alveolar Epithelial Cells

Interleukin-1 Induces Beta-Calcitonin Gene-Related Peptide Secretion In Human Type Ii Alveolar Epithelial Cells

Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airways

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

Monocyte Chemotactic Protein-Inducing Protein 1 Negatively Regulating Asthmatic Airway Inflammation And Mucus Hypersecretion Involving Gamma-Aminobutyric Acid Type A Receptor Signaling Pathway In Vivo And In Vitro

Upregulation of Phosphodiesterase-4 in the Lung of Allergic Rats.

Interleukin-28B dampens protease-induced lung inflammation via IL-25 and TSLP inhibition in epithelial cells

Therapeutic Potential of Anti-Il-1β IgY in Guinea Pigs with Allergic Asthma Induced by Ovalbumin

Pharmacokinetics and Anti-asthmatic Potential of Non-parenterally Administered Recombinant Human Interleukin-1 Receptor Antagonist in Animal Models

Monocyte chemotactic protein-inducing protein 1 negatively regulating asthmatic airway inflammation and mucus hypersecretion involving γ-aminobutyric acid type A receptor signaling pathway in vivo and in vitro

Regulation of Th17/Treg Function Contributes to the Attenuation of Chronic Airway Inflammation by Icariin in Ovalbumin-Induced Murine Asthma Model.

Calcitonin Gene-Related Peptide Inhibits Interleukin-1Beta-induced Endogenous Monocyte Chemoattractant Protein-1 Secretion in Type II Alveolar Epithelial Cells.

Epimedin C modulates the balance between Th9 cells and Treg cells through negative regulation of noncanonical NF-κB pathway and MAPKs activation to inhibit airway inflammation in the ovalbumin-induced murine asthma model

Small Proline-Rich Protein 3 Regulates IL-33/ILC2 Axis to Promote Allergic Airway Inflammation

Pulmonary epithelial CCR3 promotes LPS-induced lung inflammation by mediating release of IL-8.

Calcitonin gene-related peptide inhibits interleukin-1β-induced interleukin-8 secretion in human type II alveolar epithelial cells

Effects of endothelin B receptor antagonists, BQ788 and ET-111-21 fragment on the bronchoconstriction elicited by isocapnic hyperpnea in guinea pigs

The role of PDE4 in pulmonary inflammation and goblet cell hyperplasia in allergic rats.